The pharmaceutical industry is undergoing a structural shift where ESG considerations are no longer peripheral but central to growth strategies. Increasing regulatory pressure, investor scrutiny, and stakeholder expectations are compelling companies to embed sustainability into core operations. In 2025, over 70% of global pharmaceutical firms reported enhanced ESG disclosures, reflecting a broader move toward transparency and accountability. Environmental concerns such as car

How to Make Your Coffee Habit More Sustainable How much coffee do you consume every day? For me, the answer varies. It really depends on how tired I am and how busy my schedule is. Have you ever thought about the relationship between coffee and ESG? A New ESG Reality: Coffee at the Center of Global Deforestation Policy In 2026, coffee is no longer just a commodity—it is a compliance issue, a climate risk factor, and a frontline ESG priority. The European Union Deforestation R

The Rising Energy Demand of AI Artificial intelligence (AI) has quickly become one of the most energy-intensive drivers of digital transformation. From large language models (LLM) to hyperscale data centers, the computational demand behind AI systems is surging. Recent industry discussions highlight how AI growth and workloads could significantly increase global electricity consumption over the next decade. This trend is raising urgent questions for ESG leaders: can innovati

In ESG and sustainability, taxonomies refer to classification systems that define what counts as environmentally sustainable , socially responsible , or well‑governed economic activities. In simple terms: A taxonomy is a rulebook that tells investors which activities are truly “green” or “sustainable.” These taxonomies help: prevent greenwashing guide investors toward credible ESG investments create a common language for sustainability across markets support policy and r